59 related articles for article (PubMed ID: 15939469)
1. Interferon beta increases c-Myc proteolysis in mouse monocyte/macrophage leukemia cells.
Hu X; Bies J; Wolff L
Leuk Res; 2005 Nov; 29(11):1307-14. PubMed ID: 15939469
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
[TBL] [Abstract][Full Text] [Related]
3. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
[TBL] [Abstract][Full Text] [Related]
4. Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest.
Vairo G; Vadiveloo PK; Royston AK; Rockman SP; Rock CO; Jackowski S; Hamilton JA
Oncogene; 1995 May; 10(10):1969-76. PubMed ID: 7761098
[TBL] [Abstract][Full Text] [Related]
5. Defining the mechanism by which IFN-beta dowregulates c-myc expression in human melanoma cells: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35).
Sarkar D; Park ES; Fisher PB
Cell Death Differ; 2006 Sep; 13(9):1541-53. PubMed ID: 16410805
[TBL] [Abstract][Full Text] [Related]
6. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
8. Transfection of fibroblasts with activated c-myc confers resistance to antigrowth effects of interferon.
Einat M; Kimchi A
Oncogene; 1988 May; 2(5):485-91. PubMed ID: 2453829
[TBL] [Abstract][Full Text] [Related]
9. HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma.
Zhang QL; Luo CL; Wu XH; Wang CY; Xu X; Zhang YY; Liu Q; Shen SL
J Cell Biochem; 2011 Oct; 112(10):2910-9. PubMed ID: 21618595
[TBL] [Abstract][Full Text] [Related]
10. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
13. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
Wang X; Lu R; Fang JY
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
[TBL] [Abstract][Full Text] [Related]
14. [The influence of different WT1 gene isoforms expression pattern on the differentiation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):543-7. PubMed ID: 16468332
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
Lin CP; Liu JD; Chow JM; Liu CR; Liu HE
Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602
[TBL] [Abstract][Full Text] [Related]
17. IFN-alpha enhances TNF-alpha-induced apoptosis through down-regulation of c-Myc protein expression in HL-60 cells.
Nakashima A; Kumakura S; Mishima S; Ishikura H; Kobayashi S
J Exp Clin Cancer Res; 2005 Sep; 24(3):447-56. PubMed ID: 16270532
[TBL] [Abstract][Full Text] [Related]
18. AP4 encodes a c-MYC-inducible repressor of p21.
Jung P; Menssen A; Mayr D; Hermeking H
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of c-myc and the transferrin receptor in G1 synchronized M1 myeloid leukemia cells.
Neckers LM; Tsuda H; Weiss E; Pluznik DH
J Cell Physiol; 1988 May; 135(2):339-44. PubMed ID: 3372600
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc.
Benanti JA; Wang ML; Myers HE; Robinson KL; Grandori C; Galloway DA
Mol Cancer Res; 2007 Nov; 5(11):1181-9. PubMed ID: 17982115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
